INTRODUCTION
Heterocyclic ring containing compounds are of great value both medicinally and industrially. 1 Five-membered heterocycles demonstrated their efficacy in medicinal chemistry. Oxadiazole scaffold containing one oxygen and two nitrogen atoms in the five membered ring is a heterocyclic compound of great significance. Oxadiazole ring act as a pharmacophore in various clinically used number of drugs such as Raltegravir, Zibotentan, Furamizole. 2, 3 It is derived by replacement of two methane (-CH=) group by two pyridine type nitrogen (-N=) from furan. Depending on the position of nitrogen atom in the ring, oxadiazole exists in four possible isomers. 1, 3, 4-oxadiazole is widely exploited isomer in the area of drug discovery because of their broad range of biological activities. Literature survey revealed that the 1,3,4-oxadiazole derivatives is found to bear on the compilation of latest update on biological profile of 1,3,4-oxadiazole derived compounds.
PHARMACOLOGICAL ACTIVITY

Anti-Diabetic Activity
Oxadiazole derivatives have been extensively studied for their anti-diabetic effect. A small series of novel benzothiazole clubbed oxadiazole mannich bases were synthesized and evaluated for their anti-hyperglycemic activity in STZ-induced model by R. Bhutani et al. 4 All the compounds exhibited good to moderate activity and the compound 1 ( Figure 1) showed highest anti-diabetic activity. A novel series of derivatives of 3-[2-(methyl amino) methyl]-5-{[(2-phenylquinazolin-4-yl)oxy]methyl}-1,3,4-oxadiazole-2(3H)-thione were prepared by Srinivas S et al. and were screened for GSK-3Β inhibition activity. 5 Three of the compounds 2, 3 and 4 of oxadiazolo-quinazoline series ( Figure 2 ) exhibited good hypoglycemic activity.
A new series of fifteen 3-(5-cyclohexyl-1,3,4-oxadiazo-2-yl)N-substituted aniline analogs were prepared by S. Kavitha et al. and were screened for in vitro alphaamylase inhibition activity. 6 Among all the synthesized hits, compound 5 ( Figure 3 ) and 6 ( Figure 4) showed good α amylase inhibition activity than other compounds. A.K. Iqbal et al. synthesized some novel thiazolidinone derivatives incorporating oxadiazole moiety and the compounds were evaluated for in vivo hypoglycemic activity in wistar rats. 7 Compound 7 ( Figure 5 ) showed comparable hypoglycemic activity to Pioglitazone. Derivatives of oxadiazole containing 2-mercapto benzimidazole derivatives were synthesized and investigated for anti-diabetic activity using Oral Glucose Tolerance Test (OGTT) by R.V. Shingalapur et al. 8 Compounds 8(a-d) ( Figure 6 ) were found to have outstanding activity against standard. S. Kun et al. synthesized a series of 2-(β-D-Glucopyranosyl)-5-(4,hydroxymethyl-1,2,3-triazol-1,-ylmethyl)-1,3,4-oxadiazole derivatives. 9 Analogs were assayed against rabbit muscle glycogen phosphorylase b. Compound 9 Figure 7 ) was found to had best inhibition.
Antimicrobial activity
Synthesis of novel benzothiazole based 1,3,4-oxadiazole derivatives containing benzothiazole were reported by Taher P. et al. 10 Compounds 10(a-d) ( Figure 8 ) synthesized were evaluated for antimicrobial active and they demonstrated good activity against Staphylococcus aureus, Escherichia coli. using isonicotinohydrazide and were found active against Staphylococcus aureus, Escherichia coli, Bacillus cereus.
11
Compounds (11a), (11d) having 2-chloro and 2-methylsubstitution respectively to the phenyl nucleus exhibited moderate to good activity against gram-negative bacteria and compounds (11b), (11c) having 3-chloro and 4-chloro substitution respectively to the phenyl nucleus exhibited moderate to good activity against gram positive bacteria only. (Figure 9 ) ( Figure 11 ) showed magnificent activity against both gram positive and gram negative bacteria. Salahuddin et al. developed a new series of oxadiazole bearing benzimidazole system as potent antibacterial and antifungal agents. 14 It was indicated that that the compounds possessing electron withdrawing group and weakly activating group showed excellent activity against E. coli and S. aureus. The derivatives with Cl, NO 2 , Br and methyl group in the oxadiazole system, compounds 14(a-d) were most potent against fungal strains. (Figure 12) A novel series of substituted 1,3,4-oxadiazole derivatives 12(a-d) ( Figure 10 ) were synthesized by Maryam Kouhkan et al. and investigated for their antimicrobial activity. 12 All of the synthesized hits showed excellent antibacterial activity against Staphylococcus aureus and Staphylococcus epidermidis. A small library of 1,4-benzodioxane based oxadiazole derivatives were synthesized by H. Khalilullah et al. using an efficient synthetic route and were investigated for antibacterial activity. 13 Compounds 13a, 13b and 13c 2,5-disubstituted-1,3,4-oxadiazoles. 17 Compound OSD (compound 17) ( Figure 15 ) was found to be better of the two compounds anti-inflammatory activity which may be due to the presence of o-phenol substitution at position 2 of oxadiazole ring. Almasirad et al. designed and synthesized a new series of methyl-imidazolyl-1,3,4-oxadiazoles and were screened for anti-inflammatory activity. A series of ten new 1,3,4-oxadiazole derivatives bearing benzothiazole moiety were synthesized and screened for their antimicrobial potential by Gollapalli Naga Raju et al. 15 Compounds 15a, 15b, 15d and 15e showed significant antibacterial activity while 15c and 15e ( Figure 13 ) showed good antifungal activity.
Anti-inflammatory activity
G. Chawla et al. reported the syntheses and evaluation of 2-(3-bromo4-fluorophenyl)-5-substituted-1,3,4-oxadiazoles as anti-inflammatory agent. 16 The pharmacological results revealed that, compound 16 ( Figure 14 ) in which aryl ring was replaced by naphthyl ring, showed highest anti-inflammatory activity. Durgashivaprasad et al. had explored the anti-inflammatory activity in acute and chronic models of two novel terium tuberculosis H37Rv and isoniazid resistant M. tuberculosis.
Chandrasekera et al. tested the potential of newly synthesized 3-substituted benzothiophene-1,1-dioxide derivatives as inhibitors of virulent Mycobacterium tuberculosis. 23 The results revealed that the substitution at the C-3 position of the benzothiophene-1,1dioxide series influenced the anti-tubercular activity. Oxadiazoles 24(a-d) ( Figure 21 ) showed good anti-tubercular were found equipotent to standard in inhibiting the rat paw edema. 
Anti-alzheimer Activity
Attaby et al. synthesized a number of new heterocyclic compounds, some having 1,3,4-oxadiazole derivatives and all were tested for anti-alzheimer activity. 27 Many compounds showed good activity and compound 28 ( Figure 25 ) having oxadiazole moiety found to have high potency as anti-alzheimer agents relative to Flurbiprofen. New chemical entities having 1,3,4-oxadiazole moiety of were synthesized and tested for their in vitro acetylcholinesterase (AChE) inhibitory potency by Kamal et al. 28 All compounds derived exhibited good inhibitory activity against AChE enzyme. Derivative 29 ( Figure 26) showed IC 50 value of 37.65 IM and resulted as a promising anti-alzheimer agent Saitoh et al. designed, synthesized and reported SAR of a new library of oxadiazole derivatives as GSK-3β inhibitors which is promising agent for treating alzheimer's disease. 29 Among all derivatives compound 30 ( Figure 27 ) . 25 Results of anti-tubercular activity against M. tuberculosis revealed that compound26 ( Figure 23 ) showed two fold enhanced potency than parent compound. Ladania GG et al. synthesized new series of hits by coupling 1,3,4-oxadiazole with substituted quinoline moiety using molecular hybridization using different catalyst and solvents. 26 Primary screening of obtained compounds were performed against Mycobacterium tuberculosis H37Rv strain using Lowenstein-Jensen medium. The result showed that compounds 27(a-d) ( Figure 24) were found to possess excellent activity. Abdelmonem et al. synthesized some novel oxadiazole derivatives and tested for antioxidant activity. 31 All derivatives, compound 32 ( Figure 29 ) were found to be potent antioxidant agents. Patrao et al. synthesized a new entities of 1-(substituted)-2-({5-[(naphthalen-1/2 yloxy) methyl]-1,3,4-oxadiazol-2-yl}sulfanyl)ethanone. They were tested for antioxidant activities and showed promising results. 32 Compound 33 ( Figure 30 ) exhibited good antioxidant activity. A library of new 5-(2-amino-5-methylthiazol-4-yl)-1,3,4-oxadiazole-2-thiol derivatives was prepared and evaluated was found to show high selectivity and potency for GSK-3β inhibition in vitro.
Antioxidant Activity
Shridhar et al. synthesized novel 3,5-Bis(alkyl-1,3,4-oxadiazole-2-yl azo dyes 4(a-f) and tested for in vitro antioxidant properties. 30 Results showed that all compounds have significant antimicrobial and antioxidant activities. DPPH assay was done on 4a-f at different concentrations and 31a and 31b ( Figure 28 ) showed significant DPPH scavenging activity (>70%) due to best substitutions. synthesized hits 38 and 39 ( Figure 35 ) possess good significant activity. Docking study was also done of all the prepared compounds on PDB ID: 4COF.
A new series of 2-(substituted phenyl)amino-5-(4-pyridyl)-4H-1,3,4-oxadiazole derivatives was synthesized from isoniazid and various substituted isothiocyanates by M Shaharyar et al. 38 Synthesized compounds were screened for their anticonvulsant activity. Compound 2-(4-chlorophenyl) amino-5-(4-pyridyl)1,3,4-oxadiazole (40) (Figure 36) found to have extremely good anticonvulsant activity. Harish Rajak et al. designed and synthesized a series of new substituted semicarbazones containing 1,3,4oxa-diazole nucleus, 41(a-n) ( Figure 37 ) and tested for their anticonvulsant potential through MES and scPTZ models. 39 Results demonstrated that hits bearing the groups like hydroxy or nitro on phenyl possess high potency in MES and scPTZ models. Tabatabai A et al. synthesized some phenoxyphenyl-1,3,4-oxadiazole derivatives and evaluated them for anticonvulsant activity using pentylene tetrazole induced lethal convulsion test. 40 It was indicated that compound 42 ( Figure 38 ) with an amino substituent on 5 position of 1,3,4-oxadiazole ring has a good effect whereas for antioxidant potential by Kikkeri et al. 33 Compounds 34a, 34b and 34c ( Figure 31) gives best scavenging effect against the free radicals. Novel series of 2,5-disubstituted-1,3,4-oxadiazole derivatives synthesized and screening for their antimicrobial and antioxidant activities were done by Sindhe et al. 34 The results showed that 35(a-c) (Figure 32 ) displayed best antioxidant activity. Mihailovic et al. synthesized some 1,3,4-oxadiazole derivatives having phenolic acid moieties and examined for their scavenging potential ie.anti-oxidant activity by scavenging stable DPPH (2,2-diphenyl-1-picrylhydrazyl) radicals. 35 Compounds 36(a-d) ( Figure 33 ) exhibited best DPPH scavenging activity. Bharatiya et al. synthesized a novel set of 2-N-phenyl piperazino methylene-4-(4'-amino, 2'-nitro phenyl)-5-mercapto-1,3,4-oxadiazole analogs which were tested for their antioxidant potential. 36 Compounds 37a and 37b ( Figure 34 ) showed good antioxidant activity.
Anticonvulsant activity
Vaishali and Bahar Ahmed synthesized 2-(substitutedphenyl)-2-methyl-5styryl-2,3-dihydro- [1, 3, 4] oxadiazole derivatives as anticonvulsant agents. 37 Among the replacement of amino group with H, OH, SH or SCH 3 diminish the anticonvulsant effect. A library of novel phthalimide derivatives of 1,3,4-oxadiazole were synthesized and screened for their anticonvulsant activity by Mashooq A. Bhat et al. 41 Results showed that a number of synthesized title compounds demonstrated good activity with compound 43 (Figure 39 ) showing excellent anti convulsant activity comparable to standard i.e. phenytoin. S J Gilani et al. synthesized a novel series of Isoninicotinic acid hydrazide incorporated derivatives of substitution of a free hydroxyl sugar moiety increases the antiviral activity compared to O-acetylated substituted derivatives. A new library of novel 1,3,4-oxadiazole thioether derivatives bearing 2-methylpyrimidin-4-amine group were synthesized by W. Wu et al. and evaluated for their antiviral activity against TMV. 44 Antiviral results demonstrated that compound 46 ( Figure 42) showed the best effect against TMV, even better than standard. Liangrun Dong et al. performed the synthesis of novel thioether derivatives containing 1,3,4-oxadiazole/thiadiazole and emodin moieties. 45 The derivatives were evaluated for antiviral activity against TMV using the 1,3,4-oxadiazole and were screened for anticonvulsant activity against maximal electroshock induced seizures (MES) and subcutaneous pentylenetetrazole (scPTZ) induced models. 42 All the synthesized compounds 44 (a-h) ( Figure 40 ) were found to be active in MES and most of compounds were found active in scPTZ model. Figure  43 )possessed significant antiviral activity with inhibition rates of 50.51%, 52.08% and 54.62%, respectively, which were comparable to that of reference (53.40%). Xiuhai Gan et al. designed and synthesized a novel series of 1,4-pentadien-3-one derivatives containing the 1,3,4-oxadiazole moiety and screened for their anti-viral activity. 46 It was indicated that some of the synthesized compounds showed moderate to good antiviral activities at 500 mg L , which were better to ribavirin. A small library of twenty six new 1,3,4-oxadiazole/ thiadiazole-chalcone analogs were prepared and tested for antiviral activity. 47 Compounds 49(a-b) ( Figure 45 ) showed outstanding anti-viral activity with the EC 50 values of 33.66, 33.97, 33 .87 and 30.57 mg/mL, respectively, with reference to standard. SAR study was also done which indicated that smaller aromatic ring and electron-with drawing groups will increase the anti-TMV effect.
Anti-cancer
Salahuddin et al. synthesised new 2,5-disubstituted 1,3,4-oxadiazole analogs and were evaluated for anticancer activity. 48 Compound 50(NSC-776965) and compound 51 (NSC 776971) (Figure 46 ) showed the best results against cancer among the synthesized hits. Mohamed Jawed Ahsan et al. reported the synthesis of some oxadiazole as antiproliferative agents. 49 Compound 52 ( Figure 47 ) expressed highest antiproliferative activity towards HOP-92 human cancer cell lines at 10 M concentration. evaluation was done at the NCI, USA. It was indicated by the results that compound 57 ( Figure 51 ) as potent compound with broad spectrum of activities on cell lines.
Calcium channel blocker
Girish R. Bankara et al. tested whether the correction of endothelial dysfunction is dependent on the normalization of high blood pressure levels by synthesized 1,3,4-oxadiazole derivative (compound 58) (Figure 52 ) (NOX-1) in deoxycorticosterone acetate and NG-nitro-larginine hypertensive rats. 54 In DOCA-salt and L-NNA hypertensive rats, the mean systolic blood pressure was 185.3±4.7 and 170.2±4.1 mmHg, whereas after administration of NOX-1 to hypertensive rats, MSBB was 127.8±4.5 and 120.2±5.1mmHg, respectively. 51 The prepared derivatives were evaluated for their cytotoxic activity against 60 cancer cell lines at one dose (10 μM). Compounds 54 against HL-60 (TB) and 55 ( Figure 49 ) against MOLT-4, were found to be more active than monastrol. Ahmet Özdemir et al. synthesized some novel oxadiazole, thiadiazole and triazole analogs and were tested for their inhibitory effects on MMPs. 52 Compounds 56 (a-b) ( Figure 50 ) showed most promising anticancer effects on A549 and C6 cell lines similar to standard cisplatin. These analogs were also the most active MMP-9 inhibitors. Docking study has also been performed. A. Husain et al. designed and synthesized two novel series of benzimidazole bearing oxadiazole and triazolothiadiazoles as a potential anticancer agents. 53 Anticancer Figure 55) . 57 Various factors i.e. the change in blood pressure, heart rate, effect on Carotid Occlusion and Nordaniline pressor responses were observed for the cardiovascular study.
MAO-Inhibitors
Elias Maccioni et al. designed and synthesized 3-Acetyl-2,5-diaryl-2,3-dihydro-1,3,4-oxadiazoles derivatives 62 (a-f) ( Figure 56 ) and evaluated as inhibitors of human monoamine oxidase A and B isoform. 58 It was concluded that these prepared analogs were promising reversible and selective MAO-B inhibitors. Docking study was also performed. 
